APA
Westra T. A., Stirbu-Wagner I., Dorsman S., Tutuhatunewa E. D., de Vrij E. L., Nijman H. W., Daemen T., Wilschut J. C. & Postma M. J. (20130618). Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. : BMC infectious diseases.
Chicago
Westra Tjalke A, Stirbu-Wagner Irina, Dorsman Sara, Tutuhatunewa Eric D, de Vrij Edwin L, Nijman Hans W, Daemen Toos, Wilschut Jan C and Postma Maarten J. 20130618. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. : BMC infectious diseases.
Harvard
Westra T. A., Stirbu-Wagner I., Dorsman S., Tutuhatunewa E. D., de Vrij E. L., Nijman H. W., Daemen T., Wilschut J. C. and Postma M. J. (20130618). Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. : BMC infectious diseases.
MLA
Westra Tjalke A, Stirbu-Wagner Irina, Dorsman Sara, Tutuhatunewa Eric D, de Vrij Edwin L, Nijman Hans W, Daemen Toos, Wilschut Jan C and Postma Maarten J. Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. : BMC infectious diseases. 20130618.